| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.0071 | 0.8 |
| mRNA | OSI-906 | CTRPv2 | pan-cancer | AAC | 0.0083 | 0.8 |
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | -0.0082 | 0.8 |
| mRNA | FQI-1 | CTRPv2 | pan-cancer | AAC | 0.011 | 0.8 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.0083 | 0.8 |
| mRNA | CAY10576 | CTRPv2 | pan-cancer | AAC | -0.0091 | 0.8 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0086 | 0.8 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0085 | 0.8 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.8 |